1Kar S, Sakeguchi K, Shimohigashi Y, et al. Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem, 2002,77:15579-15585.
2Zacchi P, Gostissa M, Uchlda T, et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.Nature, 2002,419:853-857.
3Grossman SR. p300/CBP/p53 interaction and regulation of the p53.Eur J Biochem,2001,268 :2773-2778.
4Fujiwara T, Grimm EA, Mukhopadhyay T, et al. A retroviral wildtype p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res, 1993,8:4129-4133.
5Toschi E, Rota R, Antoninl A, et al. Wild-Type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells. J Invest Dermatol,2000, 114.1188-1194.
6Tadahisa S, Philip JT, Timothy SS, et all. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glimna correlates with site-specific phosphorylation. Cancer Res,2002,62:1069-1176.
7Xu L, Tang WH, Huang CC, et all. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med,2001,7 :723-734.
8Mikata K, Uemura H, Ohuchi H, et all. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation. Mol Cancer Ther,2002, 1:247-252.
9Watanabe T, Sullenger BA. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts.Proc Natl Acad Sci U S A,2000,97:8490-8494.
10Hamilton A J, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science, 1999,286:950-952.
